Sanctuary Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119M Sell
474,171
-5,026
-1% -$1.08M 0.55% 27
2026
Q1
$104M Buy
479,197
+128
+0% +$28.4K 0.56% 28
2025
Q4
$109M Buy
479,069
+6,911
+1% +$1.57M 0.6% 28
2025
Q3
$109M Sell
472,158
-8,271
-2% -$1.68M 0.63% 27
2025
Q2
$89.2M Sell
480,429
-3,937
-0.8% -$732K 0.55% 29
2025
Q1
$101M Sell
484,366
-3,471
-0.7% -$675K 0.71% 22
2024
Q4
$85.7M Sell
487,837
-40,965
-8% -$7.53M 0.54% 30
2024
Q3
$93.6M Buy
528,802
+101,455
+24% +$18.9M 0.59% 26
2024
Q2
$68.2M Buy
+427,347
New +$70.8M 0.5% 32

Other funds holding ABBV

Sanctuary Advisors's ABBV Position: Q2 2026 in Review

Sanctuary Advisors reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $1.08M and leaving 474,171 shares worth $119M. The position accounts for 0.55% of the portfolio, ranked #27.

Sanctuary Advisors first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sanctuary Advisors held 474,171 shares of AbbVie worth $119M as of Q2 2026.
  • Sanctuary Advisors sold 5,026 AbbVie shares in Q2 2026, an estimated $1.08M.
  • AbbVie made up 0.55% of Sanctuary Advisors's portfolio in Q2 2026, its #27 holding.
  • Sanctuary Advisors first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.